Results 11 to 20 of about 74,556 (215)

Micronutrient in hyperphenylalaninemia

open access: yesData in Brief, 2015
The data presented here are the biochemical parameters of 156 patients with hyperphenylalaninemia. PKU patients, who, in order to maintain optimal serum Phe concentrations, receive dietary treatment consisting of a diet low in natural protein ...
Vanesa Crujeiras   +8 more
doaj   +5 more sources

Mild hyperphenylalaninemia: to treat or not to treat [PDF]

open access: yesJournal of Inherited Metabolic Disease, 2011
Abstract One of the issues to be resolved in phenylketonuria is whether patients with mild hyperphenylalaninemia need treatment, or in other words, in what patients treatment needs to be started. Do patients need treatment when phenylalanine concentrations in blood are >360 μmol/L or >600 μmol/L?
Francjan J. van Spronsen   +1 more
openaire   +4 more sources

A Case of DNAJC12-Deficient Hyperphenylalaninemia Detected on Newborn Screening: Clinical Outcomes from Early Detection

open access: yesInternational Journal of Neonatal Screening
DNAJC12-deficient hyperphenylalaninemia is a recently described inborn error of metabolism associated with hyperphenylalaninemia, neurotransmitter deficiency, and developmental delay caused by biallelic pathogenic variants of the DNAJC12 gene.
Colleen Donnelly   +3 more
doaj   +2 more sources

Psychopathological Risk Assessment in Children with Hyperphenylalaninemia

open access: yesChildren, 2022
Background: Phenylketonuria (PKU) is a rare congenital disorder caused by decreased metabolism of phenylalanine determining cerebral impairments. If untreated, PKU might lead to intellectual disability, seizures and behavioral disorders.
Maria Cristina Risoleo   +8 more
doaj   +3 more sources

Cognitive functioning in mild hyperphenylalaninemia

open access: yesMolecular Genetics and Metabolism Reports, 2015
Background: Hyperphenylalaninemia is a hereditary metabolic disorder that causes elevated blood phenylalanine (Phe). Hyperphenylalaninemias are classified as Phenylketonuria PKU (Phe > 6 mg/dL) or mild hyperphenylalaninemia (mHPA) (Phe 2–6 mg/dL).
Alicia de la Parra   +4 more
doaj   +2 more sources

BH4-deficient hyperphenylalaninemia in Russia.

open access: yesPLoS ONE, 2021
A timely detection of patients with tetrahydrobiopterin (BH4) -deficient types of hyperphenylalaninemia (HPABH4) is important for assignment of correct therapy, allowing to avoid complications.
Polina Gundorova   +12 more
doaj   +2 more sources

Integrating Functional Consequence Annotation With PAH Allelic Phenotype Values Refines Prediction of Tetrahydrobiopterin Responsiveness. [PDF]

open access: yesJ Inherit Metab Dis
ABSTRACT Tetrahydrobiopterin (BH4; sapropterin) responsiveness in phenylalanine hydroxylase (PAH) deficiency is genotype dependent, yet many patients remain untested. Allelic phenotype values (APV) summarize allele severity, but responsiveness can be heterogeneous within APV strata. We assessed whether integrating functional consequence annotation from
Himmelreich N, Blau N.
europepmc   +2 more sources

Hyperphenylalaninemia and serotonin deficiency in Dnajc12-deficient mice [PDF]

open access: yesCommunications Biology
Serotonin exerts numerous neurological and physiological actions in the brain and in the periphery. It is generated by two different tryptophan hydroxylase enzymes, TPH1 and TPH2, in the periphery and in the brain, respectively, which are members of the ...
Yunqing Cao   +7 more
doaj   +2 more sources

Phenylketonuria and glycogen storage disease type III in sibs of one family

open access: yesThe Turkish Journal of Pediatrics, 2002
Hyperphenylalaninemia result from a block in the conversion of phenylalanine into tyrosine due to a defect in either the enzyme phenylalanine hydroxylase (98% of subjects) or in the metabolism of the cofactor tetrahydrobiopterin.
Tuncay Yilmazer   +5 more
doaj   +1 more source

Increased Brown Adipose Tissue Thermogenesis in Phenylketonuria. [PDF]

open access: yesMedComm (2020)
In phenylketonuria (PKU), elevated phenylalanine (Phe) increases hepatic fibroblast growth factor 21 (FGF21) and thyroid hormones, enhancing brown adipose tissue (BAT) thermogenesis in patients. Central FGF21 reproduces this phenotype in rodents via reduced hypothalamic AMP‐activated protein kinase (AMPK) activity in the ventromedial nucleus of the ...
López-Rey N   +18 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy